Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

At the intersection of aesthetics and science, RegenCen is changing how patients think about aging. Born from a fusion of ...

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.

From celebrity talk shows to social feeds, it may feel like everyone is talking about perimenopause and menopause these days.

Here’s what experts say you should know about DIM, "good" estrogens and the future of hormone support in midlife and beyond. That ‘Natural’ Supplement Might Be Messing With Your Hormones DIM is a ...

Another study (JAMA Network Open, July 1, 2025) also found that estrogen plus progestin was associated with an increase in ...

Testosterone propionate was once a common treatment for men with low testosterone. It’s a synthetic version of the naturally ...

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.

Doctors now recognize the need to approach testosterone deficiency with the same clinical rigour as other hormone ...

The Children’s National Hospital in Washington, D.C., announced on Friday that it would no longer prescribe ...

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted ...

The U.S. Department of Justice has formally dismissed its legal challenge to Tennessee’s law prohibiting certain medical ...